10,000+ stock pitches from top investors available on joinyellowbrick.com
BAKER BROS. ADVISORS LP 13F Holdings
Holdings from the most recent 13F from BAKER BROS. ADVISORS LP
Filed: 2020-05-15 (Q1 2020) | Holdings: 110 | Value: $16.2B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| SGEN - Seattle Genetics, Inc. | 35.57% | $5.8B | -0.36% | -8.88% | |||
| INCY - Incyte Corporation | 14.42% | $2.3B | -33.53% | -0.41% | -15.95% | ||
| ACAD - ACADIA Pharmaceuticals Inc. | Add 3% ($44.4M) | 10.90% | $1.8B | -58.08% | -23.30% | -58.74% | |
| BGNE - BeiGene, Ltd. | 8.93% | $1.4B | +46.18% | +33.03% | +92.66% | ||
| ALXN - Alexion Pharmaceuticals, Inc. | Add 6% ($45.1M) | 4.84% | $786.6M | -0.80% | +68.71% | ||
| BMRN - BioMarin Pharmaceutical Inc. | 3.95% | $641.3M | -39.83% | +23.81% | -19.86% | ||
| KOD - Kodiak Sciences Inc. | Add 5% ($25.1M) | 3.40% | $552.1M | -94.22% | -17.41% | +43.85% | |
| ASND - Ascendis Pharma A/S | 2.35% | $381.8M | +13.73% | +3.56% | -5.27% | ||
| IGMS - IGM Biosciences, Inc. | 1.09% | $176.5M | -97.95% | -15.81% | +10.05% | ||
| AMRN - Amarin Corporation plc | 0.85% | $138.0M | -92.65% | -12.06% | -45.18% | ||
| ARGX - argenx SE | 0.83% | $134.3M | +264.76% | +51.64% | +76.66% | ||
| NVTA - Invitae Corporation | 0.77% | $124.4M | +85.00% | +58.78% | |||
| PRNB - Principia Biopharma Inc. | Add 9% ($9.9M) | 0.72% | $116.1M | +54.00% | |||
| MRTX - Mirati Therapeutics, Inc. | Add 8% ($7.9M) | 0.67% | $108.4M | +35.46% | +46.02% | ||
| NBIX - Neurocrine Biosciences, Inc. | Reduce 1% $(1.2M) | 0.66% | $107.3M | +3.26% | -2.07% | -21.87% | |
| EXAS - Exact Sciences Corporation | Reduce 29% $(42.9M) | 0.66% | $107.1M | -36.23% | -2.54% | +7.26% | |
| RARX - Ra Pharmaceuticals, Inc. | 0.62% | $100.5M | |||||
| MDGL - Madrigal Pharmaceuticals, Inc. | Add 28% ($22.0M) | 0.62% | $100.1M | +127.09% | -8.32% | +10.55% | |
| MYOK - MyoKardia, Inc. | 0.51% | $83.2M | -16.20% | ||||
| HRTX - Heron Therapeutics, Inc. | 0.44% | $70.7M | -87.96% | +1.73% | -13.25% | ||
| CERS - Cerus Corporation | Add 28% ($13.8M) | 0.39% | $63.8M | -76.48% | +30.93% | +7.13% | |
| ZYME - Zymeworks Inc. | 0.37% | $60.6M | -69.92% | -20.87% | -21.76% | ||
| TCDA - Tricida, Inc. | Add 35% ($15.3M) | 0.36% | $58.7M | -53.25% | -84.79% | ||
| BCEL - Atreca, Inc. | 0.36% | $58.5M | -26.64% | -52.33% | |||
| DBVT - DBV Technologies S.A. | 0.35% | $57.3M | -84.85% | -57.89% | +16.70% | ||
| AXSM - Axsome Therapeutics, Inc. | Add 7% ($3.5M) | 0.32% | $52.3M | +19.23% | -7.52% | -33.15% | |
| INSM - Insmed Incorporated | Add 24% ($9.3M) | 0.30% | $48.5M | +168.19% | +6.96% | +0.15% | |
| KNSA - Kiniksa Pharmaceuticals, Ltd. | 0.27% | $43.3M | +22.75% | -21.62% | -37.19% | ||
| RYTM - Rhythm Pharmaceuticals, Inc. | 0.25% | $41.2M | +220.76% | -3.50% | +17.13% | ||
| KRYS - Krystal Biotech, Inc. | Reduce 9% $(3.8M) | 0.25% | $40.9M | +109.93% | -25.32% | +11.48% | |
| N/A - Neurocrine Biosciences, Inc. | 0.24% | $39.3M | |||||
| NLTX - Neoleukin Therapeutics, Inc. | 0.24% | $38.7M | |||||
| CCXI - ChemoCentryx, Inc. | Add 16% ($4.8M) | 0.21% | $34.5M | +5.88% | -79.94% | ||
| ALLK - Allakos Inc. | Add 117% ($17.6M) | 0.20% | $32.7M | +32.05% | +46.35% | ||
| GWPH - GW Pharmaceuticals plc | 0.20% | $32.5M | -6.77% | ||||
| AUPH - Aurinia Pharmaceuticals Inc. | 0.15% | $24.7M | -55.17% | -17.10% | -29.73% | ||
| MRUS - Merus N.V. | 0.15% | $24.7M | +281.17% | -11.22% | +53.23% | ||
| APLS - Apellis Pharmaceuticals, Inc. | Add 80% ($10.7M) | 0.15% | $24.0M | -48.07% | -8.71% | +62.76% | |
| ASMB - Assembly Biosciences, Inc. | 0.14% | $22.9M | -94.55% | +2.08% | -81.62% | ||
| BCRX - BioCryst Pharmaceuticals, Inc. | 0.13% | $21.9M | +103.98% | -14.04% | +172.87% | ||
| FREQ - Frequency Therapeutics, Inc. | Reduce 4% $(913.1K) | 0.13% | $21.0M | ||||
| ADPT - Adaptive Biotechnologies Corporation | Reduce 33% $(10.3M) | 0.13% | $20.7M | -75.90% | +3.90% | -12.89% | |
| ALKS - Alkermes plc | Add 57% ($6.5M) | 0.11% | $17.9M | +98.14% | +19.62% | +40.64% | |
| QURE - uniQure N.V. | Reduce 31% $(7.6M) | 0.10% | $16.9M | -75.74% | -31.01% | -46.84% | |
| N/A - BioMarin Pharmaceutical Inc. | 0.10% | $15.6M | |||||
| XNCR - Xencor, Inc. | 0.08% | $12.8M | -75.86% | +3.38% | +19.79% | ||
| URGN - UroGen Pharma Ltd. | Reduce 19% $(2.8M) | 0.07% | $12.0M | -83.19% | -8.13% | -36.72% | |
| PTGX - Protagonist Therapeutics, Inc. | New Purchase | 0.07% | $11.9M | +182.39% | -1.84% | +78.88% | |
| ADAP - Adaptimmune Therapeutics plc | New Purchase | 0.06% | $10.0M | -94.05% | +79.67% | +0.20% | |
| AIMT - Aimmune Therapeutics, Inc. | 0.06% | $9.7M | -17.13% | ||||
| BOLD - Audentes Therapeutics, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| UROV - Urovant Sciences Ltd. | Reduce 100% | 0.00% | $0.00 | ||||